查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1995446

喉罩市場：2026-2032年全球市場預測（按產品類型、材料、尺寸、應用、最終用戶和分銷管道分類）

Laryngeal Mask Market by Product Type, Material, Size, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，喉罩市場價值將達到 7.2456 億美元，到 2026 年將成長至 7.5899 億美元，到 2032 年將達到 10.9167 億美元，複合年成長率為 6.03%。

主要市場統計數據
基準年 2025 7.2456億美元
預計年份：2026年 7.5899億美元
預測年份 2032 1,091,670,000 美元
複合年成長率 (%) 6.03%

對現代呼吸道管理中影響決策的設備差異、臨床權衡和採購優先事項進行全面概述。

喉頭マスクは、多様な臨床現場における呼吸道管理の基盤となるデバイスへと成熟してきましたが、技術、材料科学、医療提供モデルの融合に伴い、そのエコシステムは進化し続けています。本導入では、本レポートの調査範囲を明確にし、デバイスの運用面および商業面の動向を檢驗するための主要な觀點を提示します。重点は実用的な明確さに置かれています。すなわち、デバイスのバリエーション、材料のトレードオフ、サイズごとの臨床的考慮事項、そしてエンドユーザーが日常診療や救急医療において喉頭マスクをどのように活用しているかを理解することです。

材料技術的飛躍、醫療保健服務的演變以及更嚴格的監管，是如何重塑產品藍圖、臨床醫生的期望和銷售管道的？

喉頭マスクの市場環境は、臨床的な期待、製造技術の革新、そして変化する医療提供の枠組みに牽引され、変革的な変化を遂げています。材料科学の進歩、特に医療用シリコーン配合の改良やPVC複合材料の高度化により、密閉性能と患者の快適性が向上した一方で、滅菌通訊協定やライフサイクルコストにも影響を及ぼしています。こうした材料開発は製品藍圖を再定義しており、メーカーは產品系列やアフターサービス支援モデルを見直すよう迫られています。

本研究評估了近期關稅調整如何改變整個醫療設備價值鏈的供應鏈韌性、籌資策略和採購行為。

醫療設備の輸入に影響を与える関税の賦課および再調整は、製造経済、サプライチェーン設計、および採購慣例に重大な調整をもたらしました。関税の変更は、たとえ対象が限定されたものであっても、原料の調達、外部委託された部品製造、および国境を越えた組裝がしばしば複数の管轄区域にまたがっているため、コスト構造全体に波及します。その結果、メーカーや經銷商は、突発的な関税の急上昇によるリスクを最小限に抑えるために、サプライヤーの多様化、契約条件、および在庫戦略を見直す必要に迫られています。

從產品類型和材料到尺寸、最終用戶、分銷管道和應用，細分的各個相互交織的維度如何驅動差異化的臨床和商業策略。

セグメンテーションの知見は、製品の属性、素材、サイズ区分、エンドユーザーの環境、通路、および臨床用途がどのように相互作用し、臨床的效用と商業性的魅力に影響を与えるかを明らかにします。製品タイプに基づくと、使い捨てと再利用可能なオプションは、それぞれ異なる価値提案を生み出します。使い捨てデバイスは、単回使用による感染管理と物流の簡素化を求める購入者を惹きつけますが、再利用可能なバリエーションは、ライフサイクルコストと環境への配慮を優先する組織に支持されます。素材に基づくと、PVCとシリコーンはそれぞれ、コスト効率と生体適合性の間でトレードオフが生じます。PVCは多くの場合、単価の低さを実現しますが、シリコーンはより柔らかい表面感觸と患者の耐容性の向上により好まれます。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和採購實踐決定了臨床引進和供應商策略。

地域ごとの動向は、臨床導入、調達行動、およびサプライヤー戦略を形作る、独自の運用および法規環境を生み出しています。南北アメリカでは、多様な医療提供体制と大規模病院ネットワークの集中が購買決定に影響を与えており、臨床的エビデンス、サプライチェーンの信頼性、そして大量使用と緊急時対応を支援する契約条件が重視されています。また、この地域におけるケアモデルの外来処置への移行は、選択的手術と緊急処置の両方の環境において、効率的な患者処理と予測可能な性能を可能にするデバイスへの需要を牽引しています。

競爭定位分析著重於以臨床證據驅動差異化、供應鏈韌性和以客戶為中心的商業模式。

競争の動態は、専門的な醫療設備のイノベーターから大規模多角化医療サプライヤーに至るまで、幅広い企業群によって形成されています。各社は、設計上の差別化、製造地、サービス提供内容に基づいた独自のポジショニングを追求しています。主要メーカーは、性能に関する主張を裏付け、麻酔科医や救急医療従事者における導入の障壁を低減するため、材料調査、臨床医向けトレーニングプログラム、市販後データの収集に投資しています。これらの活動は、臨床的な信頼性を確立し、機器の信頼性が極めて重要となるセグメントにおけるプレミアムなポジショニングを支えるのに役立ちます。

為製造商和供應商提供切實可行的策略，以加快產品採用速度、加強供應鏈，並使產品系列與最終用戶的營運重點保持一致。

業界の領導企業は、商業性的な牽引力、臨床での採用、および運用上のレジリエンスを強化するために、いくつかの実践的な取り組みを進めることができます。まず、シール性能や挿入の成功率だけでなく、滅菌経路、ライフサイクルへの影響、特定の患者サイズにおける治療成果にも対処する臨床エビデンスの創出を優先すべきです。査読付き研究や実世界エビデンス（RWE）計劃への投資は、臨床医の信頼を加速させ、多様な医療現場における薬剤採用リストへの掲載を後押しすることになります。

透過整合一手訪談、證據綜合和情境分析，並採用高度透明、受臨床醫生影響的混合方法，我們獲得了關於醫療設備。

本分析の基盤となる調查方法は、臨床医、調達負責人、サプライチェーン管理者との一次定性調査を統合し、規制基準、臨床文献、公共政策の動向に関する2次調査で補完するものです。一次インタビューでは、構造化された通訊協定に従い、病院および外来環境における使用事例の優先順位、滅菌実務、調達上の制約を明らかにしました。これらの直接的な知見は、デバイスの機能がどのように臨床的および運営上の成果につながるかを文脈化する上で極めて重要でした。

策略重點的整合表明，臨床有效性、營運柔軟性和供應鏈透明度是長期部署和成功的關鍵。

結論では、本レポートの核心的な要点を統合し、バリューチェーン全体の利害相關人員に対する戦略的示唆を強調しています。喉頭マスクは呼吸道管理の中心的な役割を果たし続けるでしょうが、商業性的成功の決定要因は変化しつつあります。素材の性能、臨床的檢驗、サプライチェーンの俊敏性、そしてカスタマイズされた商業性的関与が、市場におけるリーダーとフォロワーをますます明確に区別するようになっています。製品開発を臨床医のワークフローや調達の実情に積極的に適合させる組織こそが、より大きな信頼を獲得し、長期的な採用を実現することになるでしょう。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：喉罩市場：依產品類型分類

  • 一次性的
  • 可重複使用的

第9章：喉罩市場：依材料分類

  • PVC
  • 矽酮

第10章：喉罩市場：依尺寸分類

  • 成人版
  • 新生
  • 適合兒童

第11章：喉罩市場：依應用領域分類

  • 緊急呼吸道管理
  • 全身麻醉

第12章：喉罩市場：依最終用戶分類

  • 門診手術中心
  • 醫院

第13章：喉罩市場：依通路分類

  • 直銷
  • 線上
  • 零售

第14章：喉罩市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：喉罩市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：喉罩市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國喉罩市場

第18章：中國喉罩市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Ambu A/S
  • ICU Medical, Inc.
  • Intersurgical Ltd.
  • Jiangsu RemeGen Co., Ltd.
  • Medtronic plc
  • Pro-Tech Medical, Inc.
  • Smiths Group plc
  • SunMed LLC
  • Teleflex Incorporated
  • VBM Medizintechnik GmbH
Product Code: MRR-4103B31E052A

The Laryngeal Mask Market was valued at USD 724.56 million in 2025 and is projected to grow to USD 758.99 million in 2026, with a CAGR of 6.03%, reaching USD 1,091.67 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 724.56 million
Estimated Year [2026] USD 758.99 million
Forecast Year [2032] USD 1,091.67 million
CAGR (%) 6.03%

A comprehensive orientation to device variants, clinical trade-offs, and procurement priorities that shape modern airway management decision making

The laryngeal mask has matured into a cornerstone device for airway management across diverse clinical settings, yet its ecosystem continues to evolve as technology, materials science, and care delivery models converge. This introduction establishes the report's scope and frames the primary lenses through which the device's operational and commercial dynamics are examined. The emphasis is on practical clarity: understanding device variants, material trade-offs, size-specific clinical considerations, and how end users deploy laryngeal masks in routine and emergent care.

Clinicians increasingly evaluate laryngeal masks not only for immediate airway protection but also for their role in workflow efficiency, patient throughput, and perioperative safety. Consequently, purchasing decisions now weigh durability, sterilization pathways, and compatibility with existing respiratory equipment alongside clinical performance metrics. This context sets the stage for subsequent sections that dissect regulatory influences, competitive positioning, and actionable pathways for manufacturers and healthcare systems.

Through a synthesis of clinical literature, procurement patterns, and stakeholder interviews, the introduction positions readers to appreciate the nuanced balance among disposable convenience, reusable durability, silicone biocompatibility, PVC economics, and the varying needs of adult, pediatric, and neonatal populations. The goal is to offer a concise yet comprehensive orientation that primes executive decision-makers for the deeper analytical narratives that follow.

How material breakthroughs, care delivery evolution, and regulatory tightening are reshaping product roadmaps, clinician expectations, and commercial channels

The landscape for laryngeal masks is experiencing transformative shifts driven by clinical expectations, manufacturing innovation, and changing care delivery frameworks. Advances in material science, notably improved medical-grade silicone formulations and refined PVC composites, have enhanced seal performance and patient comfort while simultaneously influencing sterilization protocols and lifecycle costs. These material developments are redefining product roadmaps, prompting manufacturers to rethink product portfolios and after-sales support models.

Parallel to material innovation, procedural trends are reshaping demand. The expansion of ambulatory surgery and the emphasis on minimally invasive procedures have elevated the importance of airway devices that enable rapid turnover and predictable performance. At the same time, emergency airway management protocols increasingly favor devices that combine ease of insertion with reliability under variable clinical conditions. As a result, product development is aligning more closely with clinician workflow needs, incorporating feedback loops from frontline users and anesthesiology teams.

Regulatory scrutiny and standards evolution are also catalyzing change, with tighter expectations around biocompatibility, labeling, and post-market surveillance. These developments are encouraging manufacturers to strengthen quality systems and invest in clinical evidence generation. Meanwhile, distribution channels are diversifying: digital procurement platforms and direct sales models are gaining traction, challenging traditional retail intermediaries. Collectively, these shifts are driving a competitive environment that rewards clinical validation, supply chain resilience, and adaptive commercial strategies.

Assessing how recent tariff adjustments are altering supply chain resilience, sourcing strategies, and procurement behaviors across the medical device value chain

The imposition and recalibration of tariffs affecting medical device imports have introduced material adjustments across manufacturing economics, supply chain design, and procurement practices. Tariff changes, even when targeted, ripple through cost structures because raw material sourcing, outsourced component manufacturing, and cross-border assembly often span multiple jurisdictions. As a consequence, manufacturers and distributors have had to reassess supplier diversification, contract terms, and inventory strategies to limit exposure to sudden duty escalations.

Procurement teams within hospitals and ambulatory centers respond to tariff-driven cost pressures by negotiating longer-term agreements, consolidating orders, and exploring alternative suppliers that offer local or tariff-exempt supply chains. For some organizations, tariffs have accelerated conversations around reshoring or nearshoring production to reduce trade exposure and improve lead-time predictability. These decisions carry trade-offs: while localized production can improve responsiveness, it may require additional capital investment, regulatory approvals, and quality assurance ramp-up.

From a competitive standpoint, tariff shifts can advantage manufacturers with vertically integrated operations or with established domestic production footprints, enabling them to offer more stable pricing and supply assurances. Conversely, smaller suppliers that rely heavily on cross-border inputs may face margin compression and heightened pressure to innovate their service offerings. In clinical settings, the downstream effect is a renewed emphasis on supply chain transparency, contract flexibility, and collaborative forecasting between suppliers and clinical procurement teams to sustain device availability under evolving trade conditions.

How intertwined segmentation dimensions-from product type and material to size, end user, channel, and application-drive differentiated clinical and commercial strategies

Segmentation insights reveal how product attributes, materials, size categories, end-user environments, distribution pathways, and clinical applications interact to influence clinical utility and commercial appeal. Based on Product Type, disposable and reusable options create distinct value propositions: disposable devices attract buyers seeking single-use infection control and simplified logistics, whereas reusable variants appeal to organizations prioritizing lifecycle cost and environmental considerations. Based on Material, PVC and silicone each present trade-offs between cost efficiency and biocompatibility; PVC often supports lower unit pricing, while silicone is favored for softer interfaces and improved patient tolerance.

Based on Size, adult, neonatal, and pediatric classifications require tailored design parameters, cuff geometry, and insertion protocols, making size-specific clinical evidence and training critical to safe deployment. Based on End User, ambulatory surgical centers prioritize throughput, ease of use, and predictable disposability, while hospitals balance versatility across emergency airway management and general anesthesia with procurement cycles and sterilization infrastructure. Based on Distribution Channel, direct sales relationships support customized contracting and clinical support, online channels drive broader accessibility and price transparency, and retail pathways remain relevant for certain consumable formats.

Based on Application, emergency airway management demands devices optimized for rapid placement under variable conditions, whereas general anesthesia applications prioritize seal integrity and long-duration comfort. Understanding how these segmentation dimensions overlap enables manufacturers to tailor development priorities, messaging, and post-sale services to align with clinical workflows and procurement expectations across diverse care settings.

Regional dynamics and procurement behaviors across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine clinical adoption and supplier strategies

Regional dynamics create distinct operational and regulatory contexts that shape clinical adoption, procurement behavior, and supplier strategies. In the Americas, diverse healthcare delivery systems and a concentration of large hospital networks influence purchasing decisions, with emphasis on clinical evidence, supply chain reliability, and contractual terms that support high-volume usage and emergency readiness. Transitioning care models toward outpatient procedures in this region also drive demand for devices that enable efficient patient throughput and predictable performance across both elective and emergency settings.

In Europe, Middle East & Africa, regulatory harmonization efforts, variable reimbursement frameworks, and a wide spectrum of healthcare infrastructure sophistication require flexible commercial approaches. Some markets within this region prioritize high-end material performance and robust clinical validation, while others favor cost-effective solutions and simplified supply models. Local manufacturing incentives and regional procurement consortia can further influence supplier entry strategies and partnership models.

Asia-Pacific presents a heterogeneous mix of advanced tertiary centers and rapidly developing healthcare systems, fostering both demand for premium devices and opportunity for scalable, cost-conscious alternatives. Investments in domestic manufacturing capabilities, combined with evolving clinical training programs, are supporting broader adoption across pediatric and neonatal applications. Across all regions, interoperability with existing equipment, post-market surveillance expectations, and logistical considerations drive supplier differentiation and strategic planning.

Competitive positioning analysis emphasizing clinical evidence, supply chain resilience, and customer-centric commercial models that drive differentiation

Competitive dynamics are shaped by a spectrum of companies ranging from specialized device innovators to large diversified medical suppliers, each pursuing distinct positioning grounded in design differentiation, manufacturing footprint, and service offerings. Leading manufacturers invest in materials research, clinician training programs, and post-market data collection to substantiate performance claims and reduce adoption friction among anesthesiologists and emergency medicine practitioners. These activities help establish clinical credibility and support premium positioning in segments where device reliability is mission-critical.

Smaller and mid-sized companies differentiate through nimble product development cycles, targeted niche solutions for pediatric or neonatal care, and value-added services such as sterilization partnerships and educational initiatives. Distribution-focused firms emphasize channel optimization, leveraging direct sales for hospital systems and e-commerce for broader market reach. Strategic collaborations between manufacturers and hospital systems to conduct in-situ evaluations and real-world evidence collection are becoming more common and influence procurement decisions.

Across the competitive landscape, successful companies demonstrate strength in three areas: clinical evidence generation, supply chain resilience, and customer-centric commercial models. Firms that align these competencies with regulatory compliance, environmental considerations, and digital engagement models are best positioned to win preference among clinicians and procurement leaders alike.

Actionable strategies for manufacturers and suppliers to accelerate adoption, fortify supply chains, and align product portfolios with end-user operational priorities

Industry leaders can pursue several pragmatic actions to strengthen commercial traction, clinical adoption, and operational resilience. First, prioritize clinical evidence generation that addresses not only seal performance and insertion success but also sterilization pathways, lifecycle implications, and outcomes in specific patient sizes. Investing in peer-reviewed studies and real-world evidence projects will accelerate clinician confidence and support formulary inclusion across diverse care settings.

Second, diversify manufacturing and supplier relationships to mitigate tariff exposure and supply chain disruption. Nearshoring certain production stages and establishing validated secondary suppliers for critical components can reduce lead-time volatility and enable more competitive contract terms. Third, align product portfolios with the nuanced needs of end users: develop differentiated disposable options for ambulatory settings while offering reusable models with streamlined reprocessing pathways for hospitals prioritizing lifecycle cost efficiencies. Fourth, strengthen digital and direct sales capabilities to provide tailored contracting, clinician training, and post-sale analytics that demonstrate value in operational metrics such as turnover time and device reliability.

Finally, embed sustainability and environmental impact considerations into product development and packaging decisions, as procurement committees increasingly weigh ecological footprints alongside cost and clinical performance. By combining targeted clinical programs, flexible manufacturing strategies, and customer-centric commercial models, industry players can convert disruption into competitive advantage.

A transparent, clinician-informed mixed-methods approach integrating primary interviews, evidence synthesis, and scenario analysis to generate actionable device insights

The research methodology underpinning this analysis integrates primary qualitative engagements with clinicians, procurement officers, and supply chain managers, supplemented by secondary review of regulatory standards, clinical literature, and public policy developments. Primary interviews followed a structured protocol to elicit use-case priorities, sterilization practices, and procurement constraints across hospital and ambulatory environments. These firsthand insights were critical for contextualizing how device features translate into clinical and operational outcomes.

Secondary analysis involved a systematic examination of technical standards, material safety documentation, and peer-reviewed clinical studies to validate performance characteristics and to surface emerging best practices in insertion technique and post-market monitoring. Cross-referencing regulatory guidance documents allowed for assessment of compliance considerations and their implications for product labeling and risk management. Triangulation of primary and secondary inputs ensured the narrative balanced frontline experience with documented evidence.

Analytic approaches included thematic synthesis of qualitative data, scenario analysis to explore supply chain sensitivity to policy shifts, and comparative profiling of product features and services. Quality assurance steps comprised peer review by clinical advisors and methodologists to confirm that conclusions reflect robust interpretation of the evidence base. The methodology emphasizes transparency and reproducibility while prioritizing actionable insight for decision-makers.

Synthesis of strategic priorities showing that clinical validation, operational flexibility, and supply chain transparency will determine long-term adoption and success

The conclusion synthesizes the report's core takeaways and underscores strategic implications for stakeholders across the value chain. Laryngeal masks will remain central to airway management, but the determinants of commercial success are shifting: material performance, clinical validation, supply chain agility, and tailored commercial engagement increasingly distinguish market leaders from followers. Organizations that proactively align product development with clinician workflows and procurement realities will capture greater trust and long-term adoption.

Regulatory dynamics and trade policy considerations will continue to influence operational decisions, making supply chain transparency and manufacturing flexibility essential components of risk management. End users-whether ambulatory surgical centers or hospital systems-will favor partners that can demonstrate consistent device performance, evidence-backed benefits, and adaptable support models. For manufacturers, this implies a need to invest in clinical studies, training programs, and diversified sourcing strategies.

Ultimately, success will favor companies that balance innovation with pragmatism: delivering devices that meet clinical needs, comply with evolving standards, and integrate seamlessly into clinical and procurement workflows. Those that do so can drive improved patient outcomes while maintaining resilient and commercially viable operations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Laryngeal Mask Market, by Product Type

  • 8.1. Disposable
  • 8.2. Reusable

9. Laryngeal Mask Market, by Material

  • 9.1. PVC
  • 9.2. Silicone

10. Laryngeal Mask Market, by Size

  • 10.1. Adult
  • 10.2. Neonatal
  • 10.3. Pediatric

11. Laryngeal Mask Market, by Application

  • 11.1. Emergency Airway Management
  • 11.2. General Anesthesia

12. Laryngeal Mask Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals

13. Laryngeal Mask Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Online
  • 13.3. Retail

14. Laryngeal Mask Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Laryngeal Mask Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Laryngeal Mask Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Laryngeal Mask Market

18. China Laryngeal Mask Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Ambu A/S
  • 19.6. ICU Medical, Inc.
  • 19.7. Intersurgical Ltd.
  • 19.8. Jiangsu RemeGen Co., Ltd.
  • 19.9. Medtronic plc
  • 19.10. Pro-Tech Medical, Inc.
  • 19.11. Smiths Group plc
  • 19.12. SunMed LLC
  • 19.13. Teleflex Incorporated
  • 19.14. VBM Medizintechnik GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL LARYNGEAL MASK MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LARYNGEAL MASK MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL LARYNGEAL MASK MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL LARYNGEAL MASK MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL LARYNGEAL MASK MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LARYNGEAL MASK MARKET SIZE, BY SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL LARYNGEAL MASK MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LARYNGEAL MASK MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL LARYNGEAL MASK MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LARYNGEAL MASK MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL LARYNGEAL MASK MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL LARYNGEAL MASK MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES LARYNGEAL MASK MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA LARYNGEAL MASK MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL LARYNGEAL MASK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL LARYNGEAL MASK MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LARYNGEAL MASK MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LARYNGEAL MASK MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LARYNGEAL MASK MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LARYNGEAL MASK MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LARYNGEAL MASK MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LARYNGEAL MASK MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LARYNGEAL MASK MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LARYNGEAL MASK MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LARYNGEAL MASK MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LARYNGEAL MASK MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LARYNGEAL MASK MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LARYNGEAL MASK MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LARYNGEAL MASK MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LARYNGEAL MASK MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LARYNGEAL MASK MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LARYNGEAL MASK MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LARYNGEAL MASK MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LARYNGEAL MASK MARKET SIZE, BY NEONATAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LARYNGEAL MASK MARKET SIZE, BY NEONATAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LARYNGEAL MASK MARKET SIZE, BY NEONATAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LARYNGEAL MASK MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LARYNGEAL MASK MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LARYNGEAL MASK MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LARYNGEAL MASK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LARYNGEAL MASK MARKET SIZE, BY EMERGENCY AIRWAY MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LARYNGEAL MASK MARKET SIZE, BY EMERGENCY AIRWAY MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LARYNGEAL MASK MARKET SIZE, BY EMERGENCY AIRWAY MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LARYNGEAL MASK MARKET SIZE, BY GENERAL ANESTHESIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LARYNGEAL MASK MARKET SIZE, BY GENERAL ANESTHESIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LARYNGEAL MASK MARKET SIZE, BY GENERAL ANESTHESIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LARYNGEAL MASK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LARYNGEAL MASK MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LARYNGEAL MASK MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LARYNGEAL MASK MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LARYNGEAL MASK MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LARYNGEAL MASK MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LARYNGEAL MASK MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LARYNGEAL MASK MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LARYNGEAL MASK MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LARYNGEAL MASK MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LARYNGEAL MASK MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LARYNGEAL MASK MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LARYNGEAL MASK MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LARYNGEAL MASK MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL LARYNGEAL MASK MARKET SIZE, BY RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LARYNGEAL MASK MARKET SIZE, BY RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LARYNGEAL MASK MARKET SIZE, BY RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LARYNGEAL MASK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS LARYNGEAL MASK MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS LARYNGEAL MASK MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS LARYNGEAL MASK MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS LARYNGEAL MASK MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS LARYNGEAL MASK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS LARYNGEAL MASK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS LARYNGEAL MASK MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA LARYNGEAL MASK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA LARYNGEAL MASK MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA LARYNGEAL MASK MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA LARYNGEAL MASK MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA LARYNGEAL MASK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA LARYNGEAL MASK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA LARYNGEAL MASK MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA LARYNGEAL MASK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA LARYNGEAL MASK MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA LARYNGEAL MASK MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA LARYNGEAL MASK MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA LARYNGEAL MASK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA LARYNGEAL MASK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA LARYNGEAL MASK MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA LARYNGEAL MASK MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA LARYNGEAL MASK MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA LARYNGEAL MASK MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA LARYNGEAL MASK MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA LARYNGEAL MASK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA LARYNGEAL MASK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA LARYNGEAL MASK MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE LARYNGEAL MASK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE LARYNGEAL MASK MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE LARYNGEAL MASK MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE LARYNGEAL MASK MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE LARYNGEAL MASK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE LARYNGEAL MASK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE LARYNGEAL MASK MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST LARYNGEAL MASK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST LARYNGEAL MASK MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST LARYNGEAL MASK MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST LARYNGEAL MASK MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST LARYNGEAL MASK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST LARYNGEAL MASK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST LARYNGEAL MASK MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA LARYNGEAL MASK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA LARYNGEAL MASK MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA LARYNGEAL MASK MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA LARYNGEAL MASK MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA LARYNGEAL MASK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA LARYNGEAL MASK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA LARYNGEAL MASK MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC LARYNGEAL MASK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC LARYNGEAL MASK MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC LARYNGEAL MASK MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC LARYNGEAL MASK MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC LARYNGEAL MASK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC LARYNGEAL MASK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC LARYNGEAL MASK MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL LARYNGEAL MASK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN LARYNGEAL MASK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN LARYNGEAL MASK MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN LARYNGEAL MASK MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN LARYNGEAL MASK MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN LARYNGEAL MASK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN LARYNGEAL MASK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN LARYNGEAL MASK MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. GCC LARYNGEAL MASK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GCC LARYNGEAL MASK MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. GCC LARYNGEAL MASK MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 118. GCC LARYNGEAL MASK MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 119. GCC LARYNGEAL MASK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. GCC LARYNGEAL MASK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. GCC LARYNGEAL MASK MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION LARYNGEAL MASK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION LARYNGEAL MASK MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION LARYNGEAL MASK MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION LARYNGEAL MASK MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPEAN UNION LARYNGEAL MASK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPEAN UNION LARYNGEAL MASK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION LARYNGEAL MASK MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS LARYNGEAL MASK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS LARYNGEAL MASK MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS LARYNGEAL MASK MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS LARYNGEAL MASK MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 133. BRICS LARYNGEAL MASK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. BRICS LARYNGEAL MASK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS LARYNGEAL MASK MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. G7 LARYNGEAL MASK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. G7 LARYNGEAL MASK MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. G7 LARYNGEAL MASK MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. G7 LARYNGEAL MASK MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. G7 LARYNGEAL MASK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. G7 LARYNGEAL MASK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. G7 LARYNGEAL MASK MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. NATO LARYNGEAL MASK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. NATO LARYNGEAL MASK MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. NATO LARYNGEAL MASK MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 146. NATO LARYNGEAL MASK MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 147. NATO LARYNGEAL MASK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. NATO LARYNGEAL MASK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. NATO LARYNGEAL MASK MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL LARYNGEAL MASK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED STATES LARYNGEAL MASK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED STATES LARYNGEAL MASK MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED STATES LARYNGEAL MASK MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES LARYNGEAL MASK MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES LARYNGEAL MASK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES LARYNGEAL MASK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES LARYNGEAL MASK MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. CHINA LARYNGEAL MASK MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 159. CHINA LARYNGEAL MASK MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. CHINA LARYNGEAL MASK MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA LARYNGEAL MASK MARKET SIZE, BY SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. CHINA LARYNGEAL MASK MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA LARYNGEAL MASK MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA LARYNGEAL MASK MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)